SEARCH

SEARCH BY CITATION

References

  • 1
    Passalacqua G, Durham S. ARIA update: Allergen immunotherapy. JACI 2007;119:881891.
  • 2
    Bousquet J, Schunemann HJ, Bousquet PJ, Bachert C, Canonica GW, Casale TB et al. How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis. An ARIA-GA(2) LEN statement. Allergy 2011;66:765774.
  • 3
    Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I et al. Improving the quality of reporting of randomized studies: A CONSORT statement. JAMA 1996;276:637639.
  • 4
    Senna G, Ridolo E, Calderon M, Lombardi C, Canonica GW, Passalacqua G. Evidence of adherence to immunotherapy. Curr Opin Allergy Clin Immunol 2009;9:544548.
  • 5
    Senna G, Lombardi C, Passalacqua G, Canonica GW. How adherent to sublingual immunotherapy prescriptions are patients ? The manufacturer's point of view. J Allergy Clin Immunol 2010;126:668669.
  • 6
    Borenstein M, Hedges LV, Higgins JPT, Rotstein HR. Introduction to Meta-Analysis. West Sussex, UK: John Wiley & Sons Ltd; 2009.
  • 7
    Cooper H. Research Synthesis and Meta-Analysis: A Step-by-Step Approach. 3rd ed. Thousand Oaks, CA: Sage; 2010.
  • 8
    Stern JAC. Meta-Analysis in Stata: An Updated Collection from the Stata Journal. College Station, TX: Stata Press, 2009.
  • 9
    Scadding GK, Brostoff J. Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite. Clin Allergy 1986;16:483491.
  • 10
    Tari MG, Mancino M, Monti G. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite: a double-blind study. Allergol Immunopathol (Madr) 1990;18:277284.
  • 11
    Nelson HS, Oppenheimer J, Vatsia GA, Buchmeier A. A double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized cat extract. J Allergy Clin Immunol 1993;92:229236.
  • 12
    Casanovas M, Guerra F, Moreno C, Miguel R, Maranon F, Daza JC. Double-blind, placebo-controlled clinical trial of preseasonal treatment with allergenic extracts of Olea europaea pollen administered sublingually. J Investig Allergol Clin Immunol 1994;4:305314.
  • 13
    Feliziani V, Lattuada G, Parmiani S, Dall'Aglio PP. Safety and efficacy of sublingual rush immunotherapy with grass allergen extracts. A double blind study. Allergol Immunopathol (Madr) 1995;23:224230.
  • 14
    Troise C, Voltolini S, Canessa A, Pecora S, Negrini AC. Sublingual immunotherapy in Parietaria pollen-induced rhinitis: a double-blind study. J Investig Allergol Clin Immunol 1995;5:2530.
  • 15
    Hirsch T, Sahn M, Leupold W. Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (D.pt.) in children. Pediatr Allergy Immunol 1997;8:2127.
  • 16
    Horak F, Stubner P, Berger UE, Marks B, Toth J, Jager S. Immunotherapy with sublingual birch pollen extract. A short-term double-blind placebo study. J Investig Allergol Clin Immunol 1998;8:165171.
  • 17
    Hordijk GJ, Antvelink JB, Luwema RA. Sublingual immunotherapy with a standardised grass pollen extract: a double-blind, placebo-controlled study. Allergol Immunopathol (Madr) 1998;26:234240.
  • 18
    Passalacqua G, Albano M, Fregonese L, Riccio A, Pronzato C, Mela GS et al. Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis. Lancet 1998;351:629632.
  • 19
    Bousquet J, Scheimann P, Guinnepain MT, Perin-Fayolle M, Sauvaget J, Tonnel AB et al. Sublingual-swallow immunotherapy in patients with asthma due to house dust mite: a double-blind placebo controlled study. Allergy 1999;54:249260.
  • 20
    Clavel R, Bousquet J, Andre C. Clinical efficacy of sublingual-swallow immunotherapy: a double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis. Allergy 1998;53:493498.
  • 21
    La Rosa M, Ranno C, Andre C, Carat F, Tosca MA, Canonica GW. Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 1999;104:425432.
  • 22
    Mungan D, Misirligil Z, Gürbüz L. Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma-a placebo controlled study. Ann Allergy Asthma Immunol 1999;82:485490.
  • 23
    Passalacqua G, Albano M, Riccio A, Fregonese L, Puccinelli P, Parmiani S et al. Clinical and immunologic effects of a rush sublingual immunotherapy to Parietaria species: a double-blind, placebo-controlled trial. J Allergy Clin Immunol 1999;104:964968.
  • 24
    Pradalier A, Basset D, Claudel A, Couturier P, Wessel F, Galvain S et al. Sublingual-swallow immunotherapy (SLIT) with a standardised five-grass-pollen extract (drops and sublingual tablets) versus placebo in seasonal rhinitis. Allergy 1999;54:819828.
  • 25
    Caffarelli C, Sensi LG, Marcucci F, Cavagni G. Preseasonal local allergoid immunotherapy to grass pollen in children: a double-blind, placebo-controlled, randomized trial. Allergy 2000;55:11421147.
  • 26
    Guez S, Vatrinet C, Fadel R, Andre C. House-dust-mite sublingual-swallow immunotherapy (SLIT) in perennial rhinitis: a double-blind, placebo-controlled study. Allergy 2000;55:369375.
  • 27
    Pajno GB, Morabito L, Barberio G, Parmiani S. Clinical and immunologic effects of long term sublingual immunotherapy in children sensitized to mites: a double-blind, placebo-controlled study. Allergy 2000;55:842849.
  • 28
    Ariano R, Spadolini I, Panzani RC. Efficacy of sublingual immunotherapy in Cupressaceae allergy using an extract of Cupressus arizonica. A double blind study. Allergol Immunopathol 2001;29:238244.
  • 29
    Bahceciler NN, Isik U, Barlan IB, Basaran MM. Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double blind, placebo-controlled study. Pediatr Pulmonol 2001;32:4955.
  • 30
    Sanchez PA, Schamann F, Garcia JA. Sublingual immunotherapy with cat extract, personal experience. Allergol Immunopathol (Madr) 2001;29:6065.
  • 31
    Voltolini S, Modena P, Minale P, Bignardi D, Troise C, Puccinelli P et al. Sublingual immunotherapy in tree pollen allergy. Double-blind, placebo-controlled study with a biologically standardised extract of three pollens (alder, birch and hazel) administered by a rush schedule. Allergol Immunopathol (Madr) 2001;29:103110.
  • 32
    Lima M, Wilson DR, Roberts A, Walker SM, Durham SR. Grass pollen sublingual immunotherapy (SLIT) for seasonal rhinoconjunctivitis: a randomised controlled trial. Clin Exp Allergy 2002;32:507514.
  • 33
    Andre C, Perrin- FM, Grosclaude M, Couturier P, Basset D, Cornillon J et al. A double- blind placebo- controlled evaluation of sublingual immunotherapy with standardized ragweed extract in patients with seasonal rhinitis. Int Arch Allergy Immunol 2003;131:111118.
  • 34
    Ippoliti F, De Santis W, Volterrani A, Lenti L, Canitano N, Lucarelli S et al. Immunomodulation during sublingual therapy in allergic children. Pediatr Allergy Immunol 2003;14:216221.
  • 35
    Marcucci F, Sensi L, Frati F, Bernardini R, Novembre E, Barbato A et al. Effects on inflammation parameters of a double-blind, placebo controlled one-year course of SLIT in children monosensitized to mites. Allergy 2003;58:657662.
  • 36
    Mortemosque B, Bertel F, De Casamayor G, Verin P, Colin J. House dust mite sublingual-swallow immunotherapy in perennial conjunctivitis: a double-blind, placebo-controlled study. Clin Exp Allergy 2003;33:464469.
  • 37
    Wutrich B, Bucher C, Jorg W, Bircher A, Eng P, Schneider Y et al. Placebo- controlled study with sublingual immunotherapy in children with seasonal allergic rhinitis to grass pollen. J Investig Allergol Clin Immunol 2003;13:145148.
  • 38
    Bowen T, Greenbaum J, Charbonneu Y, Hebert J, Filderman R, Sussman G et al. Canadian trial of sublingual swallow immunotherapy for ragweed rhinoconjuctivitis. Ann Allergy Asthma Immunol 2004;93:425430.
  • 39
    Bufe A, Ziegler-Kirbach E, Stoeckman E, Heidemann P, Gehlhar K, Holland-Letz T et al. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms, a double-blind, placebo-controlled study. Allergy 2004;59:498504.
  • 40
    Khinchi MS, Poulsen LK, Carat F, Andre C, Hansen AB, Malling HJ. Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study. Allergy 2004;59:4553.
  • 41
    Rolinck-Werninghaus C, Wolf H, Liebke C, Baars JC, Lange J, Kopp MV. A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhino-conjuctivitis to grass pollen. Allergy 2004;59:12851293.
  • 42
    Tonnel AB, Scherpereel A, Douay B, Mellin B, Leprince D, Goldstein N et al. Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy. Allergy 2004;59:491497.
  • 43
    Dahl R, Stender A, Rak S. Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis. Allergy 2006;61:185190.
  • 44
    Dahl R, Kapp A, Colombo G, de Monchy JGR, Rak S, Emminger W et al. Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006;118:434440.
  • 45
    Di Rienzo V, Pucci S, D'Alo S, Di Cara G, Incorvaia C, Frati F et al. Effects of high-dose sublingual immunotherapy on quality of life in patients with cypress-induced rhinitis: a placebo-controlled study. Clin Exp Allergy Rev 2006;6:6770.
  • 46
    Durham SR, Riis B. Grass allergen tablet immunotherapy relieves individual seasonal eye and nasal symptoms, including nasal blockage. Allergy 2007;62:954957.
  • 47
    Lue KH, Lin YH, Sun HL, Lu KH, Hisieh H, Chou MC. Clinical and immunologic effect of sublingual immunotherapy in asthmatic children sensitized to house dust mites: a double-blind, randomized, placebo-controlled study. Pediatr Allergy Immunol 2006;17:408415.
  • 48
    Niu CK, Chen WY, Huang IL, Lue KH, Wang YJ. Efficacy of sublingual immunotherapy with high-dose mite extract in asthma: a multi-center, double-blind, randomized, placebo-controlled study. Respir Med 2006;100:13741383.
  • 49
    Palma-Carlos AG, Santos AS, Branco-Ferreira M, Pregal AL, Palma-Carlos ML, Bruno ME et al. Clinical efficacy and safety of preseasonal sublingual immunotherapy with grass pollen carbamylated allergoid in rhinitis patients. A double-blind, placebo- controlled study. Allergol Immunopathol (Madr) 2006;34:194198.
  • 50
    Passalacqua G, Pasquali M, Ariano R, Lombardi C, Giardini A, Baiardini I et al. Randomized double-blind controlled study with sublingual carbamylated allergoid immunotherapy in mild rhinitis due to mites. Allergy 2006;61:849854.
  • 51
    Valovirta E, Jacobsen L, Ljorring C, Koivikko A, Savolainen J. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children. Allergy 2006;61:11771183.
  • 52
    Worm M. Efficacy and tolerability of high dose sublingual immunotherapy in patients with rhinoconjunctivitis. Eur Ann Allergy Immunol 2006;38:355360.
  • 53
    Alvarez CE, Berges-Gimeno P, Gonzales-Macebo E, Fernandez-Caldas E, Cuesta-Herranz J, Casanovas M. Sublingual immunotherapy with a standardized cat dander extract: evaluation of efficacy in a double-blind placebo controlled study. Allergy 2007;62:810817.
  • 54
    De Blay F, Barning C, Kanny G, Purohit A, Leynadier F, Tunon de Lara JM et al. Sublingual-swallow immunotherapy with standardized 3 grass pollen extract: a double-blind, placebo-controlled study. Ann Allergy Asthma Immunol 2007;99:453461.
  • 55
    Didier A, Malling HJ, Worm M, Horak F, Jäger S, Montagut A et al. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. J Allergy Clin Immunol 2007;120:13381345.
  • 56
    Moreno-Ancillo A, Moreno C, Ojeda P, Dominguez C, Barasona MJ, García-Cubillana A et al. Efficacy and quality of life with a once daily sublingual immunotherapy with grasses plus olive pollen extract without updosing. J Invest Allergol Clin Immunol 2007;17:399405.
  • 57
    Mosges R, Bruning H, Hessler HJ, Gotz G, Knaussman HJ. Sublingual immunotherapy in pollen-induced seasonal rhinitis and conjunctivitis: a randomized controlled trial. Acte Dermatovenerl Alp Panonica Adriat 2007;16:143148.
  • 58
    Pham-Thi N, Scheinmann P, Fadel R, Combebia A, Andre C. Assessment of sublingual immunotherapy efficacy in children with house-dust mite induced asthma optimally controlled by pharmacological treatment and mite avoidance. Pediatr Allergy Immunol 2007;18:4757.
  • 59
    Röder E, Berger MY, Hop WC, Bernsen RM, de Groot H, Gerth van Wijk R. Sublingual immunotherapy with grass pollen is not effective in symptomatic youngsters in primary care. J Allergy Clin Immunol 2007;119:892898.
  • 60
    Vervloet D, Birnbaum J, Laurent P, Hugues B, Fardeau MF, Massabie-Bouchat YP et al. Safety and efficacy of Juniperus Ashei sublingual-swallow ultra-rush pollen immunotherapy in cypress rhinoconjunctivitis: a double-blind, placebo-controlled study. Int Arch Allergy Immunol 2007;142:239246.
  • 61
    Pfaar O, Klimek L. Efficacy and safety of specific immunotherapy with a high-dose sublingual grass pollen preparation: a double-blind, placebo-controlled trial. Ann Allergy Asthma Immunol 2008;100:256263.
  • 62
    Stelmach I, Kaczmarek-Wozniak J, Majak P, Olszowiec-Chlebna M, Jerzynska J. Efficacy and safety of high doses sublingual immunotherapy in ultra rush scheme in children allergic to grass pollens. Clin Exp Allergy 2009;39:401409.
  • 63
    Bufe A, Eberle P, Franke-Beckmann E, Funck J, Kimmig M, Klimek L et al. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy. J Allergy Clin Immunol 2009;123:167173.
  • 64
    Ott H, Sieber J, Brehler R, Fölster-Holst R, Kapp A, Klimek L et al. Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study. Allergy 2009;64:179186.
  • 65
    O'Hehir RE, Gardner LM, de Leon MP, Hales BJ, Biondo M, Douglass JA et al. House dust mite sublingual immunotherapy: the role for transforming factor beta and functional regulatory T cells. Am J Respir Crit Care Med 2009;180:936947.
  • 66
    Amar SM, Harbeck RJ, Sills M, Silveira LJ, O' Brien H, Nelson HS. Response to sublingual immunotherapy with grass pollen extract: monotherapy vs combination in a multiallergen extract. J Allergy Clin Immunol 2009;124:150156.
  • 67
    Horak F, Zieglmayer P, Zieglmayer R, Lemell P, Devillier P, Montagut A et al. Early onset of action of a 5- grass-pollen 300 IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber. J Allergy Clin Immunol 2009;124:471477.
  • 68
    Voltolini S, Trise C, Incorvaia C, Bignardi D, Di Cara G, Marcucci F et al. Effectiveness of high dose sublingual immunotherapy to induce a stepdown of seasonal asthma: a pilot study. Curr Med Res Opin 2010;26:3740.
  • 69
    Leonardi S, Arena A, Bruno ME, Cannaò PM, D'Anneo RV, Falagiani P et al. Olea sublingual allergoid immunotherapy administered with two different treatment regimes. Allergy Asthma Proc 2010;31:2529.
  • 70
    Agostinis F, Foglia C, Bruno ME, Falagiani P. Efficacy, safety and tolerability of sublingual monomeric allergoid in tablets given without updosing to pediatric patients with allergic rhinitis and/or asthma due to grass pollen. Eur Ann Allergy Clin Immunol 2009;41:177180.
  • 71
    Skoner D, Gentile D, Bush R, Fasano MB, McLaughlin A, Esch RE. Sublingual immunotherapy in patients with allergic rhinoconjunctivitis caused by ragweed pollen. J Allergy Clin Immunol 2010;126:660666.
  • 72
    Cortellini G, Spadolini I, Patella V, Fabbri E, Santucci A, Severino M et al. Sublingual immunotherapy for Alternaria induced allergic rhinitis. Ann Allergy Asthma Immunol 2010;105:382386.
  • 73
    Mosges S, Graute V, Christ H, Sieber HJ, Whan U, Nieggeman B. Safety of ultra rush titration of sublingual immunotherapy in asthmatic children with tree pollen allergy. Pediatr Allergy Immunol 2010;21:11351138.
  • 74
    Yonekura S, Okamoto Y, Sakurai D, Horiguchi S, Hanazava T, Nakano A et al. Sublingual immunotherapy with house dust extract for house-dust mite allergic rhinitis in children. Allergol Int 2010;59:381388.
  • 75
    Halken S, Agertoft L, Seidenberg J, Bauer CP, Payot F, Martin-Munoz MF. Five grass pollen 300IR SLIT tablets: efficacy and safety in children and adolescents. Pediatr Allergy Immunol 2010;21:970976.
  • 76
    Pfaar O, Barth C, Jaschke C, Hormann K, Klimek L. Sublingual allergen specific immunotherapy adjuvanted with monophosphoryl lipid a: a phase I/IIa study. Int Arch Allergy Immunol 2011;154:336344.
  • 77
    Nelson HS, Nolte H, Creticos P, Maloney J, Wu J, Bernstein DI. Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North America adults. J Allergy Clin Immunol 2011;127:7280.
  • 78
    Bush RK, Swenson C, Fahlberg B, Evans MD, Esch R, Morris M et al. House dust mite sublingual immunotherapy: results of a US trial. J Allergy Clin Immunol 2011;127:974981.
  • 79
    Blaiss M, Maloney J, Nolte H, Gawchik S, Yao R, Skoner DP. Efficacy and safety of timothy grass allergy immunotherapy in North America children and adolescents. J Allergy Clin Immunol 2011;127:6471.
  • 80
    Valovirta E, Myrseth SE, Palkonen S. The voice of patients: allergic rhinitis is not a trivial disease. Curr Opin Allergy Clin Immunol 2008;8:19.
  • 81
    Baiardini I, Balestracci I, Ghiglione V, Stagi E, Ridolo E, Nathan R et al. Does asthma control correlate with quality of life related to upper and lower disease ? A real life study Allergy 2009;64:937943.
  • 82
    Pajno GB, Vita D, Caminiti L, Arrigo T, Lombardo F, Incorvaia C et al. Children compliance with allergen immunotherapy according to the administration route. J Allergy Clin Immunol 2005;116:13801381.
  • 83
    Rhodes BJ. Patients dropout before completion of optimal dose multiple allergen immunotherapy. Ann Allergy Asthma Immunol 1999;82:281286.
  • 84
    Vita D, Caminiti L, Ruggeri P, Pajno GB. Sublingual immunotherapy adherence is based on timing and monitoring control visits. Allergy 2010;65:668669.
  • 85
    Sade K, Berkun Y, Dolev Z. Knowledge and expectations of patients receiving aeroallergen immunotherapy. Ann Allergy Asthma Immunol 2003;91:444448.
  • 86
    Incorvaia C, Rapetti A, Scurati S, Puccinelli P, Capecce M, Frati F. Importance of patient's education in favouring compliance with sublingual immunotherapy. Allergy 2010;65:13411342.
  • 87
    Whalbeck K, Tuunainen A, Ahokas A, Leucht S. Dropout rates in randomized antipsychotic drug trials. Psycopharmacology 2001;155:230233.
  • 88
    Didier A, Worm M, Horak F, Sussman G, de Beaumont O, Le Gall M et al. Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis. J Allergy Clin Immunol 2011;128:559566.
  • 89
    De Bot CM, Moed H, Berger MY, Röder E, Hop WC, de Groot H et al. Sublingual immunotherapy not effective in house dust mite-allergic children in primary care. Pediatr Allergy Immunol 2012;23:150158.
  • 90
    Yukselen A, Kendirli SG, Yilmaz M, Altintas DU, Karakoc GB. Effect of one-year. Subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study. Int Arch Allergy Immunol 2012;157:288298.
  • 91
    Wahn U, Klimek L, Ploszczuk A, Adelt T, Sandner B, Trebas-Pietras E et al. High-dose sublingual immunotherapy with single-dose aqueous grass pollen extract in children is effective and safe: a double-blind, placebo-controlled study. J Allergy Clin Immunol 2012;130:886893.
  • 92
    Stelmach I, Kaluzińska-Parzyszek I, Jerzynska J, Stelmach P, Stelmach W, Majak P. Comparative effect of pre-coseasonal and continuous grass sublingual immunotherapy in children. Allergy 2012;67:312320.
  • 93
    Ahmadiafshar A, Maarefvand M, Taymourzade B, Mazloomzadeh S, Torabi Z. Efficacy of sublingual swallow immunotherapy in children with rye grass pollen allergic rhinitis: a double-blind placebo-controlled study. Iran J Allergy Asthma Immunol 2012;11:175181.
  • 94
    Bozek A, Ignasiak B, Filipowska B, Jarzab J. House dust mite sublingual immunother-apy: a double-blind, placebo-controlled study in elderly patients with allergic rhinitis. Clin Exp Allergy 2013;43:242248.
  • 95
    Creticos PS, Maloney J, Bernstein DI, Casale T, Kaur A, Fisher R et al. Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults. J Allergy Clin Immunol 2013;131:13421349.
  • 96
    Aydogan M, Eifan AO, Keles S, Akkoc T, Nursoy MA, Bahceciler NN et al. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomized trial. Respir Med 2013;107:13221329.
  • 97
    Wang DH, Chen L, Cheng L, Li KN, Yuan H, Lu JH et al. Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial. Laryngoscope 2013;123:13341340.